Phibro Animal Health Corporation (PAHC) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Phibro Animal Health Corporation  (NASDAQ: PAHC)


Phibro Animal Health's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Phibro Animal Health's ROI in the first quarter of 2026?
Phibro Animal Health Corporation achieved a return on average invested assets (ROI) of 8.48 % in its first quarter of 2026, this is above PAHC's average return on investment of 8.34%.
Phibro Animal Health Corporation invested over the 12 months ending in its first quarter of 2026 $1,211 million

ROI has improved compared to 8.2% in the fourth quarter of 2026, due to net income growth.

Within the Healthcare sector 92 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1109, from total ROI ranking in the fourth quarter of 2026 at 1112.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
I. Quarter		 (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter
Y / Y Investment Change TTM 3.86 % 15.28 % 33.97 % 45.83 % 56.53 %
Y / Y Net Income Change TTM 51.46 % 106.61 % 206.81 % 806.4 % 872.27 %
Investment (TTM) in Millions 1,219 1,210 1,293 1,123 1,236
Return On Investment (TTM) 8.48 % 8.2 % 7.84 % 7.78 % 5.82 %
PAHC's Overall Ranking # 1109 # 1112 # 174 # 1089 #
Seq. Investment Change TTM -0.36 % 0.07 % 2.6 % 1.52 % 10.6 %
Seq. Net Income Change TTM 3 % 4.71 % 3.41 % 35.79 % 40.51 %
Net Income (TTM) in Millions 103 100 95 92 68

PAHC Company Profile >> Back to PAHC Roi Comparisons >> See Annual PAHC Return On Investment



Return On Investment PAHC's Ranking
Within: No.
Industry # 33
Sector # 93
Overall # 1109

Return On Investment Statistics
High Average Low
18.81 %
8.34 %
-1.26 %
(Jun 30 2016)   (Jun 30 2014)







Financial Statements
Phibro Animal Health's I. Quarter Investments $ 1,219 Millions PAHC's Balance sheet
Phibro Animal Health's I. Quarter Income $ 30 Millions Quarterly PAHC's Income Statement
PAHC's Income by Division See PAHC's Income by Division


PAHC Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 1,185 1,067 778 795 741
Y / Y Investment Growth 10.99 % 37.2 % -2.18 % 7.36 % 9.4 %
Net Income in Millions 100 48 2 33 49
Y / Y Net Income Growth 106.61 % 1897.68 % -92.59 % -33.69 % -9.58 %
Annual Return On Investment 8.42 % 4.52 % 0.31 % 4.1 % 6.64 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 8.42 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PAHC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PAHC's Competitors
Subscribers only: Roi for Phibro Animal Health's Suppliers
Subscribers only: Return On Investment for PAHC's Customers

Other Ratios
PAHC's Roa PAHC's Inventory Turnover Ratio PAHC's Growth Rates PAHC's Dividend Statistics
PAHC's Profitability Ratios PAHC's Asset Turnover Ratio PAHC's Dividend Growth
PAHC's Roe PAHC's Valuation Ratios PAHC's Financial Strength Ratios PAHC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %

Date modified: 2026-11-06T12:55:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.